Lonza - Capsugel®
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

18

Feb 2020

Novartis receives EC Approval for Beovu®, a next-generation anti-VEGF treatment for wet AMD, a leading cause of blindness worldwide

Novartis announced the European Commission EC has approved Beovu brolucizumab injection for the treatment of wet agerelated macular degeneration AMD Beovu is the first ECapproved antiVEGF treatment to demonstrate superior resolution of retinal fluid IRFSRF a key marker of disease activity versus afl...

17

Feb 2020

PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application

PharmaMar and Jazz Pharmaceuticals plc announce that the US Food and Drug Administration FDA accepted for filing with Priority Review the New Drug Application NDA seeking accelerated approval for lurbinectedin for the treatment of patients with Small Cell Lung Cancer SCLC who have progressed after p...

15

Feb 2020

Epizyme Announces FDA Acceptance of New Drug Application for Filing with Priority Review for TAZVERIK™ (tazemetostat) for the Treatment of Follicular Lymphoma

Epizyme Inc a fully integrated commercialstage biopharmaceutical company developing novel epigenetic therapies today announced that the US Food and Drug Administration FDA has accepted for filing the companys New Drug Application NDA for the accelerated approval of TAZVERIK tazemetostat for patients...

14

Feb 2020

FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning

Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced that its RiVax heat stable ricin toxin vaccine development program for prevention of ricin intoxication has received Fast Trac...

13

Feb 2020

OSE Immunotherapeutics Announces Artificial Intelligence Antibody Drug Development Collaboration with MAbSilico

OSE Immunotherapeutics announced a new collaboration agreement with deep technology innovative startup MAbSilico located in Tours France to use artificial intelligence AIbased solutions for therapeutic antibody drug development

13

Feb 2020

WPD Pharmaceuticals to Conduct Clinical Trials in Pediatric Brain Tumors Through Collaboration With CNS Pharmaceuticals

WPD Pharmaceuticals Inc a clinical stage pharmaceutical company is pleased to announce its plan to initiate a Phase I clinical trial for Berubicin in pediatric brain cancer in Poland in collaboration with CNS Pharmaceuticals Inc a biotechnology company specializing in the development of novel treatm...

12

Feb 2020

Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers

Cannabics Pharmaceuticals Inc a leader in personalized cannabinoid medicine focused on cancer and its side effects announced today that it has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastro intestinal cancers

press releasesRead more...

18

Feb 2020

FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States

GlaxoSmithKline announced that the US Food and Drug Administration FDA has approved Voltaren Arthritis Pain diclofenac sodium topical gel NSAID arthritis pain reliever as an overthecounter OTC product for the temporary relief of arthritis pain in the hand wrist elbow foot ankle or knee in adults y...

17

Feb 2020

Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services

Inceptua Group pharma company and service partner today announces that Philip Gregory has joined Inceptua as Vice President Head of AsiaPacific Clinical Trial Services Inceptua has offices in both Japan and China where the regional Clinical Trial Services Team provides strategic sourcing and suppl...

14

Feb 2020

Promedior Announces Completion of Acquisition by Roche

Promedior Inc announced the successful completion of its previously announced sale to Roche With this acquisition Roche obtained full rights to Promediors entire portfolio of molecules for serious fibrotic diseases notably PRM Under the terms of the merger agreement Roche made an upfront cash payme...

13

Feb 2020

M8 Pharmaceuticals and Daewoong Pharmaceuticals Signed an Exclusive Licensing Agreement for Fexuprazan™ in Mexico

M Pharmaceuticals and Daewoong Pharmaceuticals announced they have signed an exclusive licensing agreement whereby m will have the rights to commercialize and promote Fexuprazan in the Mexican market The new drug Fexuprazan is a potassiumcompetitive acid blocker PCAB PCABs are regarded as the nextge...

13

Feb 2020

Prevail Therapeutics’ PR001 Receives Orphan Drug Designation and Rare Pediatric Disease Designation from FDA

Prevail Therapeutics Inc a biotechnology company developing potentially diseasemodifying AAVbased gene therapies for patients with neurodegenerative diseases announced today that the US Food and Drug Administration FDA has granted Orphan Drug Designation for the Companys investigational gene therapy...

12

Feb 2020

Elicio Therapeutics and Natera To Collaborate in Phase I/II Pancreatic Cancer Study of ELI-002

Elicio Therapeutics a next generation immunooncology company and Natera Inc a global leader in cellfree DNA testing today announced their collaboration in a prospective multicenter Phase study of ELI an Amphiphile immunooncology therapeutic targeting KRAS mutations in the adjuvant setting for patie...

EventsRead more...

19 - 20

Feb 2020

11th Annual RNA Therapeutics

SMi Group Ltd
Copthorne Tara Hotel

20 - 21

Feb 2020

Quality and GMP Compliance for Virtual Companies

DoubleTree by Hilton San Francisco Airport

20 - 21

Feb 2020

Liquid Biopsy 2020

Myriad by SANA

20 - 21

Feb 2020

Digitalization in Pharma Forum

GLC Europe
Hotel Eurostars Berlin

21 - 22

Feb 2020

Cell and Stem Cell Research

Allied Academies
Paris

24 - 26

Feb 2020

AI-ML: Drug Discovery & Development Summit

DoubleTree by Hilton Hotel San Diego

24 - 25

Feb 2020

Advertisements

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    Treatment of Cancer Using Combined Chemo-Photo Approach

    Cancer is one of the leading causes of death in both developed and developing countries and also a major public health problem This dreadful disease is spreading with continuance and increasing incidences in recent times In million cancer patients died as per the reports of World Health Organization WHO which also estimated the increase in annual cancer cases

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...